Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141


Abdominal infections in the intensive care unit: characteristics, treatment and determinants of outcome.

De Waele J, Lipman J, Sakr Y, Marshall JC, Vanhems P, Barrera Groba C, Leone M, Vincent JL; EPIC II Investigators.

BMC Infect Dis. 2014 Jul 29;14:420. doi: 10.1186/1471-2334-14-420.


Infections, antibiotic treatment and mortality in patients admitted to ICUs in countries considered to have high levels of antibiotic resistance compared to those with low levels.

Hanberger H, Antonelli M, Holmbom M, Lipman J, Pickkers P, Leone M, Rello J, Sakr Y, Walther SM, Vanhems P, Vincent JL; EPIC II Group of Investigators.

BMC Infect Dis. 2014 Sep 22;14:513. doi: 10.1186/1471-2334-14-513.


Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: results from the EPIC II study.

Hanberger H, Walther S, Leone M, Barie PS, Rello J, Lipman J, Marshall JC, Anzueto A, Sakr Y, Pickkers P, Felleiter P, Engoren M, Vincent JL; EPIC II Group of Investigators.

Int J Antimicrob Agents. 2011 Oct;38(4):331-5. doi: 10.1016/j.ijantimicag.2011.05.013. Epub 2011 Jul 28.


Impact of infection on the prognosis of critically ill cirrhotic patients: results from a large worldwide study.

Gustot T, Felleiter P, Pickkers P, Sakr Y, Rello J, Velissaris D, Pierrakos C, Taccone FS, Sevcik P, Moreno C, Vincent JL; EPIC II Group of Investigators.

Liver Int. 2014 Nov;34(10):1496-503. doi: 10.1111/liv.12520. Epub 2014 Mar 26.


The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee.

Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, Wolff M, Spencer RC, Hemmer M.

JAMA. 1995 Aug 23-30;274(8):639-44.


Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study.

Kett DH, Azoulay E, Echeverria PM, Vincent JL; Extended Prevalence of Infection in ICU Study (EPIC II) Group of Investigators.

Crit Care Med. 2011 Apr;39(4):665-70. doi: 10.1097/CCM.0b013e318206c1ca.


Infections in a surgical intensive care unit of a university hospital in Greece.

Markogiannakis H, Pachylaki N, Samara E, Kalderi M, Minettou M, Toutouza M, Toutouzas KG, Theodorou D, Katsaragakis S.

Int J Infect Dis. 2009 Mar;13(2):145-53. doi: 10.1016/j.ijid.2008.05.1227. Epub 2008 Sep 5.


Hydroxyethyl starch for fluid resuscitation in critically ill patients.

Bagshaw SM, Chawla LS.

Can J Anaesth. 2013 Jul;60(7):709-13. doi: 10.1007/s12630-013-9936-4. Epub 2013 Apr 20.


Characteristics of critically ill patients in ICUs in mainland China.

Du B, An Y, Kang Y, Yu X, Zhao M, Ma X, Ai Y, Xu Y, Wang Y, Qian C, Wu D, Sun R, Li S, Hu Z, Cao X, Zhou F, Jiang L, Lin J, Chen E, Qin T, He Z, Zhou L; China Critical Care Clinical Trial Group.

Crit Care Med. 2013 Jan;41(1):84-92. doi: 10.1097/CCM.0b013e31826a4082.


[Epidemiology of infection and sepsis in intensive care unit patients].

Le Gall JR, Alberti C, Brun Buisson C.

Bull Acad Natl Med. 2004;188(7):1115-25; discussion 1125-6. French.


A pilot randomised controlled trial in intensive care patients comparing 7 days' treatment with empirical antibiotics with 2 days' treatment for hospital-acquired infection of unknown origin.

Scawn N, Saul D, Pathak D, Matata B, Kemp I, Stables R, Lane S, Haycox A, Houten R.

Health Technol Assess. 2012 Sep;16(36):i-xiii, 1-70.


Results of the severe sepsis registry in intensive care units in Poland from 2003-2009.

Kübler A, Adamik B, Durek G, Mayzner-Zawadzka E, Gaszyński W, Karpel E, Duszyńska W.

Anaesthesiol Intensive Ther. 2015;47(1):7-13. doi: 10.5603/AIT.2015.0002.


Bacterial incidence and antibiotic sensitivity pattern in moderate and severe infections in hospitalised patients.

Ghosh A, Karmakar PS, Pal J, Chakraborty N, Debnath NB, Mukherjee JD.

J Indian Med Assoc. 2009 Jan;107(1):21-2, 24-5.


Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.

Nseir S, Di Pompeo C, Cavestri B, Jozefowicz E, Nyunga M, Soubrier S, Roussel-Delvallez M, Saulnier F, Mathieu D, Durocher A.

Crit Care Med. 2006 Dec;34(12):2959-66.


Sepsis in European intensive care units: results of the SOAP study.

Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR, Payen D; Sepsis Occurrence in Acutely Ill Patients Investigators.

Crit Care Med. 2006 Feb;34(2):344-53.


Critically ill elderly adults with infection: analysis of the extended prevalence of infection in intensive care study.

Dimopoulos G, Koulenti D, Blot S, Sakr Y, Anzueto A, Spies C, Violán JS, Kett D, Armaganidis A, Martin C, Vincent JL; Extended Prevalence of Infection in Intensive Care Study Investigators.

J Am Geriatr Soc. 2013 Dec;61(12):2065-71. Erratum in: J Am Geriatr Soc. 2014 Feb;62(2):413. J Am Geriatr Soc. 2014 Apr;62(4):794.


Surgical site infection in critically ill patients with secondary and tertiary peritonitis: epidemiology, microbiology and influence in outcomes.

Ballus J, Lopez-Delgado JC, Sabater-Riera J, Perez-Fernandez XL, Betbese AJ, Roncal JA.

BMC Infect Dis. 2015 Jul 30;15:304. doi: 10.1186/s12879-015-1050-5.


The impact of hospital and ICU organizational factors on outcome in critically ill patients: results from the Extended Prevalence of Infection in Intensive Care study.

Sakr Y, Moreira CL, Rhodes A, Ferguson ND, Kleinpell R, Pickkers P, Kuiper MA, Lipman J, Vincent JL; Extended Prevalence of Infection in Intensive Care Study Investigators.

Crit Care Med. 2015 Mar;43(3):519-26. doi: 10.1097/CCM.0000000000000754.


Supplemental Content

Support Center